abnormal neurophysiology (with Syt1AD4)
abnormal neurophysiology (with Syt1AD4), with Scer\GAL4elav.PLu, Syt1B-D3.4N.UAS
abnormal neurophysiology (with Syt1AD4), with Scer\GAL4elav-C155, Syt1C2A*-C2B*.UAS
abnormal neurophysiology | embryonic stage (with Syt1AD4), with Scer\GAL4elav.PLu, Syt1B-D3.4N.UAS
abnormal neurophysiology | embryonic stage (with Syt1AD4), with Scer\GAL4elav.PLu, Syt1C2A-D3.4N.UAS
abnormal neurophysiology | larval stage (with Syt1AD4)
abnormal neurophysiology | larval stage (with Syt1AD4), with Scer\GAL4elav-C155, Syt1UAS.Tag:MYC
lethal (with Df(2L)C144)
short lived (with Syt1AD4)
uncoordinated | adult stage (with Syt1AD4)
synaptic vesicle (with Syt1AD4), with Scer\GAL4elav.PLu, Syt1KQ.UAS
Syt1AD4/Syt1N13 transheterozygous larvae exhibit synaptic transmission defects across neuromuscular junctions, including severely defective synchronous neurotransmitter release, a large increase in failure rate following stimulation, and enhancement of the slower asynchronous phase of release. These defects are enhanced upon the expression of Syt1I426K.UAS.Tag:MYC under the control of Scer\GAL4elav-C155.
Nerve-evoked excitatory junction potentials (eEJPs) at third instar NMJs are absent in Syt1N13/Syt1AD4 mutants at either low (0.2mM) or high (1.0mM) external Ca[2+].
The frequency of spontaneous neurotransmitter release, as measured by mEJPs at third instar NMJs, is slightly but significantly increased in Syt1N13/Syt1AD4 mutants at low (0.2mM) external Ca[2+].
Scer\GAL4elav-C155-mediated expression of Syt1C2A*-C2B*.Scer\UAS in a Syt1N13/Syt1AD4 background results in spontaneous neurotransmitter release frequency (measured as mEJPs) at third instar NMJs far beyond the levels observed in controls.
Syt1N13/Syt1AD4 third instar larvae display a reduction in docked synaptic vesicles as well as a reduced vesicle density at type 1b boutons.
Scer\GAL4elav-C155-mediated expression of Syt1C2B-C2B.Scer\UAS.T:Ivir\HA1 in a Syt1N13/Syt1AD4 background results in significantly enhanced spontaneous neurotransmitter release amplitude (measured as mEJPs) at third instar NMJs above the levels observed in controls.
Syt1N13/Syt1AD4 hatching stage embryos lack the synchronous component of release when evoked release properties are recorded from muscle 6 following motor nerve stimulation in 4mM extracellular Ca[2+]. In contrast, a slower asynchronous release is uncovered. Total synaptic charge transfer following stimulation (reflecting the number of released vesicles) is reduced by 97.5% in the mutant synapses.
Expression of Syt1C2A-D3.4N.Scer\UAS under the control of Scer\GAL4elav.PLu in Syt1N13/Syt1AD4 embryos results in similar levels of evoked release and total charge transfer as wild-type controls when evoked release properties are recorded from muscle 6 following motor nerve stimulation in 4mM extracellular Ca[2+]. However, the asynchronous release seen in Syt1N13/Syt1AD4 embryos is even more prominent in Syt1N13/Syt1AD4 embryos expressing Syt1C2A-D3.4N.Scer\UAS under the control of Scer\GAL4elav.PLu. Syt1N13/Syt1AD4 embryos expressing Syt1C2A-D3.4N.Scer\UAS under the control of Scer\GAL4elav.PLu show an enhanced rate of spontaneous release compared to controls.
At lower Ca[2+] concentrations, recordings from muscle 6 following motor nerve stimulation in embryos expressing Syt1C2A-D3.4N.Scer\UAS under the control of Scer\GAL4elav.PLu in a Syt1N13/Syt1AD4 background have larger synaptic currents than controls, not only in the asynchronous component, but also in synchronous release.
Embryos expressing Syt1C2A-D3.4N.Scer\UAS under the control of Scer\GAL4elav.PLu in a Syt1N13/Syt1AD4 background show a similar level of hypertonic stimulated release as controls.
Expression of Syt1B-D3.4N.Scer\UAS under the control of Scer\GAL4elav.PLu largely suppresses the asynchronous component of release seen in Syt1N13/Syt1AD4 embryos when evoked release properties are recorded from muscle 6 following motor nerve stimulation in 4mM extracellular Ca[2+]. Only a small amount of residual synchronous release is seen in these embryos and the total charge transfer is dramatically reduced, similar to Syt1N13/Syt1AD4 embryos. Syt1N13/Syt1AD4 embryos expressing Syt1B-D3.4N.Scer\UAS under the control of Scer\GAL4elav.PLu show an enhanced rate of spontaneous release compared to controls.
Embryos expressing Syt1B-D3.4N.Scer\UAS under the control of Scer\GAL4elav.PLu in a Syt1N13/Syt1AD4 background show a similar level of hypertonic stimulated release as controls.
Evoked neurotransmitter release in Syt1AD4/Syt1N13 animals is characterized by a dramatic reduction in the overall number of vesicle fusion events, compared with controls, and a shift from fast fusion to a slower and prolonged asynchronous release of vesicles. Paired-pulse facilitation is enhanced compared with wild type across all extracellular Ca[2+] levels examined. Similar to wild type, the extent of facilitation in these mutants decreases with increasing interpulse interval. Syt1AD4/Syt1N13 mutants show a 5.6-fold reduction in the absolute number of vesicles released during the second pulse, compared with controls at identical extracellular Ca[2+].
Syt1AD4/Syt1N13 synapses show decreased evoked neurotransmitter release compared to wild-type controls. They also show a significantly slower time constant of endocytosis.
Syt1AD4/Syt1N13 synapses contain vesicles with a modest increase in diameter when at rest. After stimulation, there is a dramatic further increase in average vesicle diameter. Inspection of individual active zones demonstrates that vesicular structures with diameters greater than 10nm are observed throughout the vesicle cluster, both at the active zone and periactive zone region. The retrieval of abnormally large vesicles is on going at a time when most endocytosis has been completed in controls.
There is no difference in Ï„ values in Syt1AD4/Syt1N13; Syt1KQ.Scer\UAS Scer\GAL4elav.PLu flies in response to a 50Hz, 10s stimulus, indicating that endocytosis rate is normal at Syt1KQ.Scer\UAS synapses.
Syt1AD4/Syt1N13; Syt1KQ.Scer\UAS Scer\GAL4elav.PLu synapses at rest have a mean vesicle diameter equivalent to controls. Following stimulation, however, they show a significant further increase in mean vesicle diameter. Vesicles with diameters in excess of 80nm are observed.
Following a 50 Hz, 10 s stimulus, the peak ΔF/F SpH change in Syt1AD4/Syt1N13; Syt1B-D3.4N.Scer\UAS Scer\GAL4elav.PLuflies is reduced compared to controls, which agrees with prior electrophysiological demonstration of a decrease in evoked release. A slowed endocytosis rate constant is found at Syt1B-D3.4N.Scer\UAS rescue synapses, with an average endocytic value that is more than 2-fold slower than controls. Increasing the Ca[2+] concentration speeds the rate of endocytosis, although not to control levels.
There is no difference in Ï„ values in Syt1AD4/Syt1N13; Syt1Scer\UAS.cMa Scer\GAL4elav.PLu flies in response to a 50Hz, 10s stimulus.
There is no difference in the endocytic rate in Syt1AD4/Syt1N13; Syt1D229N.Scer\UAS Scer\GAL4elav.PLu flies compared to controls. There is also no change in mean vesicle diameter comparing rest and post-stimulation conditions.
sytAD4/sytN13 null mutants exhibit dramatically slow larval locomotion. In addition to a decrease in distance travelled and locomotor cycle number, sytAD4/sytN13 mutants display an increase in the duration of a single locomotor cycle from 1 second to approximately 6 seconds. Synaptic transmission is severely decreased in sytAD4/sytN13 mutants, which show the characteristic slow rise and decay reflecting asynchronous release and a loss of the synchronous component of fusion.
Synchronous release following stimulation of the neuromuscular junction is abolished in sytAD4/sytN13 mutants, with the appearance of residual delayed release that is not seen in controls. The population time constant for delayed release latencies is 115ms in the sytAD4/sytN13 mutants, compared to less than 6ms for synchronous release in wild type. Asynchronous release in sytAD4/sytN13 mutants shows a steep Ca2+ dependence. Release during repetitive stimulation at the sytAD4/sytN13 neuromuscular junction is asynchronous to nerve stimulation. The frequency of spontaneous miniature synaptic currents at the embryonic sytAD4/sytN13 neuromuscular junction is not increased compared to wild type. sytAD1/sytN13 mutants show synchronous release following stimulation of the neuromuscular junction, although it is greatly reduced compared to controls. The cooperative Ca2+ dependence of synchronous release is abolished. Although the absolute number of asynchronous release events is reduced in sytAD1/sytN13 mutants, the time constant for the remaining delayed release events is unchanged. The total number of vesicles release during repetitive stimulation at the sytAD1/sytN13 neuromuscular junction is reduced approximately twofold compared to wild type, but the quantal content is reduced more than 100-fold. The frequency of spontaneous miniature synaptic currents at the embryonic sytAD1/sytN13 neuromuscular junction is not increased compared to wild type. No asynchronous release following stimulation of the neuromuscular junction is seen in sytAD3/sytN13 mutants. The quantal content of synchronous release is reduced more than 10-fold, although the Ca2+ cooperativity is not altered compared to wild type. The total number of vesicles release during repetitive stimulation at the sytAD3/sytN13 neuromuscular junction is reduced approximately twofold compared to wild type, but the quantal content is reduced more than 10-fold. The frequency of spontaneous miniature synaptic currents at the embryonic sytAD3/sytN13 neuromuscular junction is not increased compared to wild type. The quantal content of nerve evoked release at the neuromuscular junction is reduced in heterozygotes compared to controls.
No obvious morphological defects.
Transheterozygote combinations with other syt alleles are lethal.
Syt1AD4/Syt1N13 has increased mortality during development phenotype, enhanceable by Syt7M1/Syt7M1
Syt1AD4/Syt1N13 has abnormal neurophysiology | larval stage phenotype, enhanceable by Syt7M1/Syt7M1
Syt1AD4/Syt1N13 has abnormal neurophysiology phenotype, non-enhanceable by Syt4BA1
Syt1AD4/Syt1N13 has uncoordinated phenotype, non-enhanceable by Scer\GAL4elav-C155/Syt7RNAi.UAS
Syt1AD4/Syt1N13 has lethal | third instar larval stage phenotype, non-suppressible by Syt7UAS.cAa/Scer\GAL4elav-C155
Syt1AD4/Syt1N13 has lethal | third instar larval stage phenotype, non-suppressible by Scer\GAL4elav-C155/Syt4UAS.cLa
Syt1AD4/Syt1N13 has lethal | third instar larval stage phenotype, non-suppressible by Scer\GAL4elav-C155/Syt4UAS.cLa/Scer\GAL4elav.PLu
Syt1AD4/Syt1N13 has abnormal locomotor rhythm | larval stage phenotype, non-suppressible by Scer\GAL4elav-C155/Syt4UAS.cLa
Syt1AD4/Syt1N13 has abnormal locomotor rhythm | larval stage phenotype, non-suppressible by Scer\GAL4elav-C155/Syt4UAS.cLa/Scer\GAL4elav.PLu
Syt1AD4/Syt1N13 has abnormal neurophysiology phenotype, non-suppressible by Syt7UAS.cAa/Scer\GAL4elav-C155
Syt1AD4/Syt1N13 has abnormal neurophysiology phenotype, non-suppressible by Scer\GAL4elav-C155/Syt4UAS.cLa
Syt1AD4/Syt1N13 has abnormal neurophysiology phenotype, non-suppressible by Scer\GAL4elav-C155/Syt4UAS.cLa/Scer\GAL4elav.PLu
Syt1AD4/Syt1N13 has abnormal locomotor rhythm | larval stage phenotype, non-suppressible by Syt7UAS.cAa/Scer\GAL4elav-C155
Scer\GAL4elav-C155, Syt1AD4/Syt1N13, Syt7RNAi.UAS has lethal | third instar larval stage phenotype
Syt1AD4/Syt1N13 has embryonic/larval neuromuscular junction | larval stage phenotype, enhanceable by Syt7M1/Syt7M1
Like Syt1AD4/Syt1N13 mutants alone, Syt1AD4/Syt1N13, Syt4BA1 double mutants display robust asynchronous release. Paired-pulse facilitation remains intact in the double mutants, with enhanced facilitation as observed in Syt1AD4/Syt1N13 mutants alone. Also similar to Syt1AD4/Syt1N13 mutants alone, the release observed during paired-pulse stimulation in the double mutants remains asynchronous compared to wild type controls.
Syt1AD4/Syt1N13 mutants that also express Syt7dsRNA.Scer\UAS under the control of Scer\GAL4elav-C155 hatch and exhibit uncoordinated and slow movements (similar to Syt1AD4/Syt1N13 mutants alone), but then die during the first larval instar stage.
Overexpression of Syt7Scer\UAS.cAa or SytIVScer\UAS.cLa, under the regulation of Scer\GAL4elav-C155, in a sytAD4/sytN13 does not rescue any aspect of the behavioral phenotype. Overexpression of Syt7Scer\UAS.cAa or SytIVScer\UAS.cLa, under the regulation of Scer\GAL4elav-C155, in a sytAD4/sytN13 null mutant background has no effect on the synaptic transmission defects. Only slow release reflecting the asynchronous component of fusion is observed with the evoked EJP unchanged from the null mutant alone. Overexpression of SytIVScer\UAS.cLa, under the regulation of both Scer\GAL4elav-C155 and Scer\GAL4elav.PLu does not rescue the sytAD4/sytN13 phenotype. However, this overexpression does result in a 96% reduction in the expected Mendelian ratios.
Syt1AD4/Syt1N13 is rescued by Scer\GAL4elav-C155/Syt1UAS.Tag:MYC
Syt1AD4/Syt1N13 is rescued by Scer\GAL4elav-C155/Syt1C2A-C2B.UAS
Syt1AD4/Syt1N13 is rescued by Scer\GAL4elav-C155/Syt1C2A*-C2B.UAS
Syt1AD4/Syt1N13 is rescued by Syt1UAS.cLa/Scer\GAL4elav.PLu
Syt1AD4/Syt1N13 is rescued by Syt1UAS.cMa/Scer\GAL4elav.PLu
Syt1AD4/Syt1N13 is rescued by Scer\GAL4elav-C155/Syt1UAS.cLa
Syt1AD4/Syt1N13 is partially rescued by Scer\GAL4elav-C155/Syt1C2A-C2B.UAS
Syt1AD4/Syt1N13 is partially rescued by Scer\GAL4elav-C155/Syt1C2A*-C2B*.UAS
Syt1AD4/Syt1N13 is partially rescued by Syt1B-D3.4N.UAS/Scer\GAL4elav.PLu
Syt1AD4/Syt1N13 is partially rescued by Syt1C2A-D3.4N.UAS/Scer\GAL4elav.PLu
Syt1AD4/Syt1N13 is not rescued by Scer\GAL4elav-C155/Syt1I426K.UAS.Tag:MYC
Syt1AD4/Syt1N13 is not rescued by Scer\GAL4elav-C155/Syt1C2A-C2B*.UAS
Syt1AD4/Syt1N13 is not rescued by Scer\GAL4elav-C155/Syt1C2A*-C2B*.UAS
Syt1AD4/Syt1N13 is not rescued by Scer\GAL4elav-C155/Syt1C2A.UAS
Syt1AD4/Syt1N13 is not rescued by Scer\GAL4elav-C155/Syt1C2A*.UAS
Syt1AD4/Syt1N13 is not rescued by Scer\GAL4elav-C155/Syt1C2B.UAS
Syt1AD4/Syt1N13 is not rescued by Scer\GAL4elav-C155/Syt1C2B*.UAS
Syt1AD4/Syt1N13 is not rescued by Scer\GAL4elav-C155/Syt1C2A-C2A.UAS.Tag:HA
Syt1AD4/Syt1N13 is not rescued by Syt1C2B-C2B.UAS.Tag:HA/Scer\GAL4elav-C155
Scer\GAL4elav-C155-mediated expression of Syt1C2A-C2B.Scer\UAS restores synchronous neurotransmitter release (measured as eEJPs) at third instar NMJs in Syt1N13/Syt1AD4 animals. Partial rescue is seen at low (0.2mM) external Ca[2+], and near full rescue at high (1.0mM) external Ca[2+].
Scer\GAL4elav-C155-mediated expression of Syt1C2A*-C2B.Scer\UAS restores synchronous neurotransmitter release (measured as eEJPs) at third instar NMJs in Syt1N13/Syt1AD4 animals. Near full rescue is seen at both low (0.2mM) and high (1.0mM) external Ca[2+].
Scer\GAL4elav-C155-mediated expression of Syt1C2A-C2B*.Scer\UAS fails to restore synchronous neurotransmitter release (measured as eEJPs) at third instar NMJs in Syt1N13/Syt1AD4 animals at either low (0.2mM) or high (1.0mM) external Ca[2+].
Scer\GAL4elav-C155-mediated expression of Syt1C2A*-C2B*.Scer\UAS fails to restore synchronous neurotransmitter release (measured as eEJPs) at third instar NMJs in Syt1N13/Syt1AD4 animals at either low (0.2mM) or high (1.0mM) external Ca[2+].
Scer\GAL4elav-C155-mediated expression of Syt1C2A.Scer\UAS fails to restore synchronous neurotransmitter release (measured as eEJPs) at third instar NMJs in Syt1N13/Syt1AD4 animals at high (1.0mM) external Ca[2+].
Scer\GAL4elav-C155-mediated expression of Syt1C2A*.Scer\UAS fails to restore synchronous neurotransmitter release (measured as eEJPs) at third instar NMJs in Syt1N13/Syt1AD4 animals at high (1.0mM) external Ca[2+].
Scer\GAL4elav-C155-mediated expression of Syt1C2A-C2A.Scer\UAS.T:Ivir\HA1 fails to restore synchronous neurotransmitter release (measured as eEJPs) at third instar NMJs in Syt1N13/Syt1AD4 animals at high (1.0mM) external Ca[2+].
Scer\GAL4elav-C155-mediated expression of Syt1C2B.Scer\UAS fails to restore synchronous neurotransmitter release (measured as eEJPs) at third instar NMJs in Syt1N13/Syt1AD4 animals at high (1.0mM) external Ca[2+].
Scer\GAL4elav-C155-mediated expression of Syt1C2B*.Scer\UAS fails to restore synchronous neurotransmitter release (measured as eEJPs) at third instar NMJs in Syt1N13/Syt1AD4 animals at high (1.0mM) external Ca[2+].
Scer\GAL4elav-C155-mediated expression of Syt1C2B-C2B.Scer\UAS.T:Ivir\HA1 fails to restore synchronous neurotransmitter release (measured as eEJPs) at third instar NMJs in Syt1N13/Syt1AD4 animals at high (1.0mM) external Ca[2+].
Scer\GAL4elav-C155-mediated expression of Syt1C2A-C2B.Scer\UAS restores spontaneous neurotransmitter release frequency (measured as mEJPs) to control levels at third instar NMJs in Syt1N13/Syt1AD4 animals at low (0.2mM) external Ca[2+].
Scer\GAL4elav-C155-mediated expression of Syt1C2A*-C2B.Scer\UAS restores spontaneous neurotransmitter release frequency (measured as mEJPs) to control levels at third instar NMJs in Syt1N13/Syt1AD4 animals at low (0.2mM) external Ca[2+].
Scer\GAL4elav-C155-mediated expression of Syt1C2A-C2B*.Scer\UAS fails to restore spontaneous neurotransmitter release frequency (measured as mEJPs) to control levels at third instar NMJs in Syt1N13/Syt1AD4 animals at low (0.2mM) external Ca[2+].
Scer\GAL4elav-C155-mediated expression of Syt1C2A*-C2B*.Scer\UAS fails to restore spontaneous neurotransmitter release frequency (measured as mEJPs) to control levels at third instar NMJs in Syt1N13/Syt1AD4 animals at low (0.2mM) external Ca[2+]. Rather, mEJP frequency is dramatically increased.
Scer\GAL4elav-C155-mediated expression of Syt1C2A-C2B.Scer\UAS partially rescues the reduction in docked synaptic vesicles and vesicle density at type 1b boutons in Syt1N13/Syt1AD4 third instar larvae.
Scer\GAL4elav-C155-mediated expression of Syt1C2A*-C2B*.Scer\UAS partially rescues the reduction in docked synaptic vesicles and vesicle density at type 1b boutons in Syt1N13/Syt1AD4 third instar larvae.
Scer\GAL4elav-C155-mediated expression of Syt1C2A.Scer\UAS fails to restore spontaneous neurotransmitter release frequency (measured as mEJPs) to control levels at third instar NMJs in Syt1N13/Syt1AD4 animals at low (0.2mM) external Ca[2+].
Scer\GAL4elav-C155-mediated expression of Syt1C2A*.Scer\UAS fails to restore spontaneous neurotransmitter release frequency (measured as mEJPs) to control levels at third instar NMJs in Syt1N13/Syt1AD4 animals at low (0.2mM) external Ca[2+].
Scer\GAL4elav-C155-mediated expression of Syt1C2B.Scer\UAS fails to restore spontaneous neurotransmitter release frequency (measured as mEJPs) to control levels at third instar NMJs in Syt1N13/Syt1AD4 animals at low (0.2mM) external Ca[2+].
Scer\GAL4elav-C155-mediated expression of Syt1C2B*.Scer\UAS fails to restore spontaneous neurotransmitter release frequency (measured as mEJPs) to control levels at third instar NMJs in Syt1N13/Syt1AD4 animals at low (0.2mM) external Ca[2+].
Scer\GAL4elav-C155-mediated expression of Syt1C2A-C2A.Scer\UAS.T:Ivir\HA1 fails to restore spontaneous neurotransmitter release frequency (measured as mEJPs) to control levels at third instar NMJs in Syt1N13/Syt1AD4 animals at low (0.2mM) external Ca[2+].
Scer\GAL4elav-C155-mediated expression of Syt1C2B-C2B.Scer\UAS.T:Ivir\HA1 fails to restore spontaneous neurotransmitter release frequency (measured as mEJPs) to control levels at third instar NMJs in Syt1N13/Syt1AD4 animals at low (0.2mM) external Ca[2+].
Scer\GAL4elav-C155-mediated expression of Syt1C2B-C2B.Scer\UAS.T:Ivir\HA1 fails to rescue the reduction in docked synaptic vesicles and vesicle density, or the increase in vesicle diameter, at type 1b boutons in Syt1N13/Syt1AD4 third instar larvae.
Expression of Syt1Scer\UAS.cLa under the control of Scer\GAL4elav.PLu completely rescues the defects in the evoked synaptic currents recorded from muscle 6 of Syt1N13/Syt1AD4 embryos following motor nerve stimulation in 4mM extracellular Ca[2+]; evoked release is fully synchronous, and few asynchronous release events are seen in the rescued animals.
Transgenic expression of sytScer\UAS.cLa (under the regulation of Scer\GAL4elav-C155) in the null sytAD4/sytN13 background is able to partially restore all the behavioral defects observed. Overexpression of sytScer\UAS.cLa (under the regulation of Scer\GAL4elav-C155) is able to restore evoked excitatory junctional potential (EJP) amplitudes to near wild-type levels in sytAD4/sytN13 mutants.
Mutant phenotype can be rescued, when homozygous or in trans to sytN6, by sytelav.PD.